BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. She wanted my help building a platform at…
BioMarin to acquire Amicus Therapeutics
In this photo illustration, the Amicus Therapeutics logo is displayed on the screen of a tablet. Sheldon Cooper…